In this work, we examine the co-expression pattern of miR-155 and TLR3 in HCC and present a cell-based approach for in situ generation of self-assembled Au-antimiRNA nanocomplexes (Au-antimiRNA NCs) for use in miRNA inhibitor delivery systems. This evidence concerns the gene TLR3 and hepatocellular carcinoma.